Showing results (101-110 of 297) with videos related to
Sort By:
Pageof 30
AIDS Care|March 31, 2017
Role of male partner involvement in ART retention and adherence in Malawi's Option B+ programAustin Wesevich, Tiwonge Mtande, Friday Saidi, et al.BMC Cancer|April 18, 2015
Circadian variation in plasma 5-fluorouracil concentrations during a 24 hour constant-rate infusionGini F Fleming, Philip Schumm, Greg Friberg, et al.Science Translational Medicine|September 29, 2012
Pharmacogenomics and patient care: one size does not fit allKathleen M Giacomini, Sook Wah Yee, Mark J Ratain, et al.Cancer Chemotherapy and Pharmacology|July 12, 2002
A phase I study of suramin with once- or twice-monthly dosing in patients with advanced cancerChristopher W Ryan, Everett E Vokes, Nicholas J Vogelzang, et al.Investigational New Drugs|August 5, 2004
Phase I clinical trial of CEP-2563 dihydrochloride, a receptor tyrosine kinase inhibitor, in patients with refractory solid tumorsSamir D Undevia, Nicholas J Vogelzang, Ann M Mauer, et al.Pharmacogenetics and Genomics|December 12, 2018
Analysis of comprehensive pharmacogenomic profiling to impact in-hospital prescribingYee Ming Lee, Keith Danahey, Randall W Knoebel, et al.Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|December 30, 2004
Prospective evaluation of body surface area as a determinant of paclitaxel pharmacokinetics and pharmacodynamics in women with solid tumors: Cancer and Leukemia Group B Study 9763Antonius A Miller, Gary L Rosner, Merrill J Egorin, et al.Value in Health Regional Issues|April 8, 2022
Pfizer and Palbociclib in China: Analyzing an Oncology Pay-for-Performance PlanGarth W Strohbehn, Jennifer H Cooperrider, Dali Yang, et al.The Journal of Pharmacology and Experimental Therapeutics|August 8, 2013
Hepatocyte nuclear factor 1 regulates the expression of the organic cation transporter 1 via binding to an evolutionary conserved region in intron 1 of the OCT1 geneValerie P O'Brien, Kristin Bokelmann, Jacqueline Ramírez, et al.Pharmacogenomics|September 13, 2013
Institutional Profile: University of Chicago Center for Personalized Therapeutics: research, education and implementation scienceM Eileen Dolan, Michael L Maitland, Peter H O'Donnell, et al.Pageof 30